Investigational Site Number 840007 — Louisville, Kentucky

Investigational Site Number 840007 is a clinical research site located in Louisville, Kentucky, United States 40213.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840007 has participated in 3 clinical trials.

Therapeutic areas: Type 2 Diabetes, Ovarian Cancer Recurrent, Atherosclerotic Cardiovascular Disease.

Sponsors: Sanofi, Esperance Pharmaceuticals Inc.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840007?

Investigational Site Number 840007 has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840007 conducted?

Investigational Site Number 840007 has 3 clinical trials on record. Their work covers Type 2 Diabetes, Ovarian Cancer Recurrent, Atherosclerotic Cardiovascular Disease.

Is Investigational Site Number 840007 accredited by Crixeo Health?

Investigational Site Number 840007 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840007?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.